Jury rules against drug company in Arkansas trial
By The Associated Press
This article was published April 10, 2012 at 4:41 p.m.
LITTLE ROCK — Jurors have ruled against a Johnson & Johnson subsidiary in Arkansas’ billion-dollar lawsuit over the antipshychotic drug Risperdal.
Arkansas contended Janssen Pharmaceuticals Inc. downplayed and hid risks associated with Risperdal. Jurors returned their verdict in favor of the state on Tuesday afternoon.
The penalty will be decided in a separate hearing before a judge.
John Lynch will have the details in tomorrow's Arkansas Democrat-Gazette.
Thank you for coming to the website of the Arkansas Democrat-Gazette. We're working to keep you informed with the latest breaking news.
Comments on: Jury rules against drug company in Arkansas trial
To report abuse or misuse of this area please hit the "Suggest Removal" link in the comment to alert our online managers. Read our Terms of Use policy.
You must login to make comments.